Novavax vaccine efficacy data promising; trials in advanced stage: Indian govt
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SATURDAY, MAY 21, 2022
SATURDAY, MAY 21, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Novavax vaccine efficacy data promising; trials in advanced stage: Indian govt

Coronavirus chronicle

Hindustan Times
16 June, 2021, 05:20 pm
Last modified: 16 June, 2021, 05:25 pm

Related News

  • Bangladesh immigrants found guilty in Bengaluru gang rape case
  • Hindu women press for access to Indian mosque, in latest dispute
  • India allows goods import from Bangladesh by rail, framework set
  • Indian police charge 30 anti-Vedanta protesters over deadly 2018 demonstration
  • India's power grid creaks under hybrid work model, heatwave

Novavax vaccine efficacy data promising; trials in advanced stage: Indian govt

On Monday, Novavax Inc said its vaccine was 90% effective at preventing symptomatic Covid-19 and 100% effective at preventing moderate and severe symptoms of the virus

Hindustan Times
16 June, 2021, 05:20 pm
Last modified: 16 June, 2021, 05:25 pm
FILE PHOTO: A Novavax logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration
FILE PHOTO: A Novavax logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration

The Indian government on Tuesday hailed the Novavax vaccine against the coronavirus disease (Covid-19) and said its efficacy data is promising and encouraging. The vaccine's clinical trials are in an advanced stage of completion in India, it added.

"What we are learning from the available data is that this vaccine is very safe and it is highly effective but what makes this vaccine relevant for today is the fact that this vaccine will be produced in India by Serum Institute," NITI Aayog member V K Paul said at a press conference.

The Serum Institute of India (SII) also produces Covishield, one of the first Covid-19 vaccines to be available in the country.

Preparatory work for the production of Novavax has been done by the SII, Paul said, adding that they are also conducting a bridging trial which is in advanced stages of completion.

"I am also hoping that they will also start trials on children, which is of a special interest to all of us. The pace of vaccination should see a renewed energy from next week onward when we will realign our efforts, that of the state and effective scale up at the ground level. Teams both at the Centre and states are working on building new guidelines for high-speed coverage of the vaccination across the country," he said.

On Monday, Novavax Inc said its vaccine was 90% effective at preventing symptomatic Covid-19 and 100% effective at preventing moderate and severe symptoms of the virus. It demonstrated 93% efficacy against predominantly circulating variants of concern and variants of interest, the company added.

"The vaccine candidate 'NVX-CoV2373' demonstrated 100 per cent protection against moderate and severe disease, 90% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial," Novavax's statement read.

The study enrolled 29,960 participants across 119 sites in the United States and Mexico to evaluate efficacy, safety and immunogenicity of the vaccine, the statement added.

World+Biz / South Asia

India / Novavax Covid-19 Vaccine / Serum Institute of India (SII)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Policies on cards to pave way for private heliports, helipads
    Policies on cards to pave way for private heliports, helipads
  • Concerns over india's wheat export ban
    Tough conditions get in way of Indian wheat import
  • Zahid Hussain/TBS Sketch
    Our problematic macroeconomic duo

MOST VIEWED

  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine
  • A man checks phone at Lujiazui financial district in Pudong, Shanghai, China March 14, 2019. Photo :Reuters
    Shanghai inches towards Covid lockdown exit, Beijing plays defence
  • North Korean leader Kim Jong Un delivers opening remarks during the 2nd Conference of Secretaries of Primary Committees of the Workers' Party of Korea (WPK), in this photo released on February 27, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS/File Photo
    N Korea reports over 200,000 fever cases for 5th day amid Covid wave
  • A worker disinfects a vehicle carrying medical oxygen, in Pyongyang. Photo: Collected
    North Korea using traditional medicine to fight Covid
  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'

Related News

  • Bangladesh immigrants found guilty in Bengaluru gang rape case
  • Hindu women press for access to Indian mosque, in latest dispute
  • India allows goods import from Bangladesh by rail, framework set
  • Indian police charge 30 anti-Vedanta protesters over deadly 2018 demonstration
  • India's power grid creaks under hybrid work model, heatwave

Features

Green-backed Heron on a tilting stalk. Photo: Enam Ul Haque

Green-backed Heron: Nothing but a prayer to catch a fish  

1h | Panorama
Illustration: TBS

‘High logistics cost weakens Bangladesh’s competitiveness’

3h | Panorama
Every morning is a new beginning for all

Seashore

3h | In Focus
2023 Rolls-Royce Phantom debuts with new illuminated grille

2023 Rolls-Royce Phantom debuts with new illuminated grille

2h | Wheels

More Videos from TBS

Photo: TBS

The right way to apply for jobs at int'l orgs

Now | Videos
Ways to retain body fragrance

Ways to retain body fragrance

22h | Videos
Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

1d | Videos
How to prepare for a job

How to prepare for a job

1d | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

6
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab